Giant viruses encode protein-making tools for host control

A new study reveals that giant viruses, like the mimivirus, encode parts of the cellular protein-making machinery, allowing them to direct their amoeba hosts more effectively. This capability blurs the line between living and non-living entities. Researchers suggest it enhances viral production even under stressful conditions.

Giant viruses have intrigued biologists since 2003, when a mimivirus was identified in a water sample from Bradford, UK. This virus, which infects amoebae, is larger than many bacteria and features intricate structures along with hundreds of genes.

Typically, viruses depend on host cells to produce proteins, but some giant viruses incorporate elements of the translation machinery—the process that converts genetic information into proteins—directly into their genomes. Translation involves ribosomes and initiation complexes in cells.

Max Fels at Harvard Medical School and colleagues investigated this in infected amoebae. They isolated ribosomes from these cells and found associated viral proteins. “That was the first hint that they could be the factors we were looking for,” says Fels.

To test the role of these viral proteins, the team modified the virus's genes to prevent their production. This reduced viral output by up to 100,000-fold and severely limited new infectious particle formation.

The findings indicate that the viral complex redirects the host's protein-synthesis system toward producing viral proteins, functioning even during nutrient shortages or oxidative stress, which normally hinder host protein synthesis.

This raises evolutionary questions: did giant viruses evolve from ancient cells, or did they acquire genes from hosts? “Giant viruses have acquired a wide range of cellular machinery from their eukaryotic hosts throughout their evolution,” notes Frank Aylward at Virginia Tech, who was not involved in the study. Gene transfer during infections, followed by natural selection, likely preserved beneficial genes.

Such viruses target single-celled hosts like amoebae, where environments vary more than in multicellular organisms, making adaptable protein control advantageous.

The mimivirus genome codes for about 1,000 proteins, but most functions remain unknown, including precise regulation during infection cycles. “Viruses have long been considered rather passive entities in the evolution of living systems,” says Hiroyuki Ogata at Kyoto University in Japan. “This study shows that giant viruses can reshape molecular systems that are otherwise stably conserved across the domains of life.”

The research appears in Cell (DOI: 10.1016/j.cell.2026.01.008).

Verwandte Artikel

Photorealistic lab scene depicting DoriVac DNA origami vaccine triggering strong immune responses in mouse and organ chip models, as an advance over mRNA vaccines.
Bild generiert von KI

DNA origami “DoriVac” shows strong immune activation in early tests, offering a potential complement to mRNA vaccines

Von KI berichtet Bild generiert von KI Fakten geprüft

Researchers at Harvard’s Wyss Institute and Dana-Farber Cancer Institute report that a DNA origami-based vaccine platform called DoriVac generated robust immune responses in mice and in a human lymph node “Organ Chip” model. The team says the approach could be easier to store and manufacture than lipid nanoparticle–delivered mRNA vaccines, though the work remains preclinical. The results were published in Nature Biomedical Engineering.

Scientists in Japan have discovered a giant virus called ushikuvirus that infects amoebae and provides evidence for the theory that viruses contributed to the evolution of complex cells. Isolated from Lake Ushiku, the virus exhibits unique structural and replication traits linking it to other giant DNA viruses. This finding, published in the Journal of Virology, deepens understanding of viral roles in eukaryotic evolution.

Von KI berichtet

Researchers at Caltech have discovered how viruses infect bacteria by disabling a key protein called MurJ, essential for cell wall construction. This mechanism, revealed through high-resolution imaging, suggests a new approach to combating antibiotic-resistant superbugs. The findings highlight convergent evolution in unrelated viruses blocking MurJ similarly.

Scientists at Scripps Research have developed a nanodisc platform that mimics viral membranes, uncovering hidden interactions in HIV and Ebola proteins that traditional methods miss. The technology allows for more accurate study of antibody responses, potentially accelerating vaccine development. The findings appear in Nature Communications.

Von KI berichtet Fakten geprüft

Researchers are urging closer monitoring of free-living amoebae—microscopic organisms found in soil and water—warning that some species can cause severe, sometimes fatal infections and can be difficult to control in water systems.

A large-scale study reveals that about one in ten people carry genetic variants making them more vulnerable to severe effects from the Epstein-Barr virus, which infects over 90 percent of the population. These variants are linked to higher viral persistence and increased risks of autoimmune diseases like multiple sclerosis and lupus. The findings, based on over 735,000 genomes, suggest pathways for targeted treatments and vaccines.

Von KI berichtet

Researchers report that a single injection of a modified herpes virus draws immune cells deep into glioblastoma tumors, leading to longer survival in a clinical trial. The therapy, tested on 41 patients with recurrent brain cancer, activates T cells that persist and attack cancer cells. Findings were published in Cell.

 

 

 

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen